Novartis
NVS
#50
Rank
$198.87 B
Marketcap
$96.30
Share price
0.39%
Change (1 day)
5.88%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

P/S ratio for Novartis (NVS)

P/S ratio as of December 2023 (TTM): 3.77

According to Novartis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.77376. At the end of 2023 the company had a P/S ratio of 4.03.

P/S ratio history for Novartis from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20234.036.94%
20223.771.33%
20213.72-14.86%
20204.36-1.11%
20194.4115.06%
20183.84-2.47%
20173.9312.4%
20163.50-15.42%
20154.141.29%
20144.0823.46%
20133.3125.02%
20122.6513.79%
20112.33-10.9%
20102.61-5.84%
20092.774.1%
20082.66-15.1%
20073.14-15.14%
20063.70-2.15%
20053.78-13%
20044.34-4.67%
20034.5516.84%
20023.90-18.42%
20014.78

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.10 8.55%๐Ÿ‡บ๐Ÿ‡ธ USA
2.36-37.50%๐Ÿ‡บ๐Ÿ‡ธ USA
4.52 19.79%๐Ÿ‡บ๐Ÿ‡ธ USA
2.42-35.80%๐Ÿ‡ซ๐Ÿ‡ท France
4.44 17.60%๐Ÿ‡บ๐Ÿ‡ธ USA
2.27-39.81%๐Ÿ‡บ๐Ÿ‡ธ USA
4.43 17.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
2.05-45.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
0.7412-80.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel